Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Solazyme, Inc. And Advises Shareholders To Contact The Firm Prior To The Lead Plaintiff Deadline

Goldberg Law PC announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California against Solazyme, Inc. (“Solazyme” or the “Company”) (NASDAQ: SZYM), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between February 27, 2014 and November 5, 2014, inclusive (the “Class Period”), have until August 24, 2015 to serve as lead plaintiff in the class action.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Solazyme is a San Francisco-based bioproducts company that produces sustainable oils from microalgae. The Company uses an industrial fermentation process to transform plant-based sugars into triglyceride oils, which are used in a wide range of products.

The complaint alleges that Solazyme made false and/or misleading statements and concealed material information concerning the production capacity of its oil producing facility in Moema, Brazil. Solazyme improperly concealed ongoing construction delays caused by inadequate access to electricity and steam utility services. The diminished capacity of Solazyme’s Brazilian oil facility was made known to the investing public on November 5, 2014, when the Company disclosed that it needed to “narrow [its] production focus to smaller volumes of higher value products.” As a result of this news, shares of Solazyme fell $4.35 per share, or 58.08 percent, to close on November 6, 2014, at $3.14 per share on heavy volume.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq. 800-977-7401
Brian Schall, Esq. 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today